Lorcaserin (APD-356; APD356; Belviq Xr; Lorqess) is an approved weight-loss drug, acting as a potent and selective 5-hydroxytryptamine 2C agonist with a Ki of 15 nM. It reduces appetite by activating 5-HT2C receptor the hypothalamus, which is known to control appetite.
纯度：≥98%
CAS：616202-92-7
